AstraZeneca PLC vs Texas Instruments Incorporated
Comparación de la capitalización de mercado a lo largo del tiempo
AstraZeneca PLC
$243.3B
Puesto #59
Texas Instruments Incorporated
$258.4B
Puesto #57
Capitalización de mercado a lo largo del tiempo
Momentos clave
- Texas Instruments Incorporated superó a AstraZeneca PLC para 1999
- AstraZeneca PLC superó a Texas Instruments Incorporated para 2000
- Texas Instruments Incorporated superó a AstraZeneca PLC para 2026
Comparación año por año
| Año | AstraZeneca PLC | Texas Instruments Incorporated | Líder |
|---|---|---|---|
| 2026 | $243.3B | $258.4B | Texas Instruments Incorporated |
| 2025 | $282.2B | $156.1B | AstraZeneca PLC |
| 2024 | $196.9B | $163.4B | AstraZeneca PLC |
| 2023 | $198.1B | $144.4B | AstraZeneca PLC |
| 2022 | $195.3B | $135.7B | AstraZeneca PLC |
| 2021 | $163.9B | $150.6B | AstraZeneca PLC |
| 2020 | $136.9B | $128.1B | AstraZeneca PLC |
| 2019 | $132.8B | $97.3B | AstraZeneca PLC |
| 2018 | $97.9B | $69.7B | AstraZeneca PLC |
| 2017 | $85.9B | $75.1B | AstraZeneca PLC |
| 2016 | $64.5B | $51.2B | AstraZeneca PLC |
| 2015 | $76.6B | $37.4B | AstraZeneca PLC |
| 2014 | $76.2B | $35.6B | AstraZeneca PLC |
| 2013 | $61.7B | $28.4B | AstraZeneca PLC |
| 2012 | $46.3B | $19.4B | AstraZeneca PLC |
| 2011 | $42.7B | $17.9B | AstraZeneca PLC |
| 2010 | $40.3B | $19.6B | AstraZeneca PLC |
| 2009 | $38.9B | $15.4B | AstraZeneca PLC |
| 2008 | $32.3B | $9.0B | AstraZeneca PLC |
| 2007 | $32.3B | $19.0B | AstraZeneca PLC |
| 2006 | $39.1B | $16.3B | AstraZeneca PLC |
| 2005 | $34.5B | $18.0B | AstraZeneca PLC |
| 2004 | $25.2B | $13.8B | AstraZeneca PLC |
| 2003 | $32.9B | $16.4B | AstraZeneca PLC |
| 2002 | $23.4B | $8.3B | AstraZeneca PLC |
| 2001 | $30.5B | $15.5B | AstraZeneca PLC |
| 2000 | $33.1B | $26.2B | AstraZeneca PLC |
| 1999 | $25.7B | $26.6B | Texas Instruments Incorporated |
| 1998 | $27.2B | $11.8B | AstraZeneca PLC |
| 1997 | $21.4B | $6.1B | AstraZeneca PLC |
| 1996 | $16.3B | $4.3B | AstraZeneca PLC |
| 1995 | $11.1B | $3.4B | AstraZeneca PLC |
| 1994 | $7.5B | $2.5B | AstraZeneca PLC |